Results 211 to 220 of about 33,428 (239)

The bromodomain revisited

Trends in Biochemical Sciences, 1997
F, Jeanmougin, J M, Wurtz, B, Le Douarin, P, Chambon, R, Losson   +4 more
openaire   +2 more sources

Bromodomain brake on AML

Science-Business eXchange, 2011
A Cold Spring Harbor–led team has used a bromodomain inhibitor to treat acute myeloid leukemia in mice, greatly expanding the therapeutic potential for this emerging drug class. Tensha Therapeutics has licensed the findings and hopes to bring a compound into Phase I trials within two years.
openaire   +1 more source

Marine natural compounds as potential CBP bromodomain inhibitors for treating cancer: an in-silico approach using molecular docking, ADMET, molecular dynamics simulations and MM-PBSA binding free energy calculations

In Silico Pharmacology
M. Ali, Fabiha Noushin, Eva Azme, M. Hasan, Neamul Hoque, Afroz Fathema Metu   +5 more
semanticscholar   +1 more source

Functions of bromodomain-containing proteins and their roles in homeostasis and cancer

Nature reviews. Molecular cell biology, 2017
T. Fujisawa, P. Filippakopoulos
semanticscholar   +1 more source

Bromodomain

2011
openaire   +2 more sources

Bromodomain

2013
Toshiya Senda, Naruhiko Adachi
openaire   +1 more source

Bromodomain

2008
openaire   +2 more sources

Bromodomains as targets for therapeutic intervention

Drug Discovery Today: Technologies, 2016
Steven G, Smith, Ming-Ming, Zhou
openaire   +2 more sources

Dual‐target inhibitors of bromodomain and extra‐terminal proteins in cancer: A review from medicinal chemistry perspectives

Medicinal Research Reviews, 2022
Guan Wang, Yi Chen, Gu He
exaly  

Bromodomain Inhibitors

2021
openaire   +1 more source